Calcitonin (CT) binding activity has been extracted from a membrane fraction of human placenta using the zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-l-propanesulphonic acid (Chaps). Approximately two-thirds of the available binding sites were extracted using 5 mM-Chaps. The binding characteristics of "25I-labelled salmon CT(25I-sCT) to the solubilized extract were similar to those obtained previously with placental membranes and other targets such as osteoclasts, renal cells and certain human cancer cell lines. 125I-sCT binding was saturable (Bmax. 75 + 6 fmol/mg of protein, n = 3) and Scatchard analysis revealed a single class of high-affinity binding sites (Kd 165 + 28 pM, n = 3). In competitive-binding studies, various species-specific CTs and CT analogues showed the same rank order of potencies as seen in CT bioassays and several unrelated peptides did not compete at high doses. A biologically active CT analogue, [Arg", 18,Lys"]sCT, derivatized with the photoreactive phenylazide cross-linking agent, N-hydroxysuccinimidyl-4-azidobenzoate, was used to identify receptor components of Mr 88000 and 71000 in both particulate placental membranes and the solubili2ed extract. Receptor components of Mr 85-90000 have been identified in other CT target cells previously using chemical-and photoaffinity-labelling techniques. These results demonstrate the first successful solubilization of the CT receptor in a form which purification.
Introduction
In mammals, calcitonin (CT) acts to inhibit bone resorption [1, 2] by interaction with specific receptors on the bone-resorbing cell, the osteoclast [3, 4] . This has been the basis of the clinical use of CT in conditions associated with excessive bone resorption such as Paget's disease and osteoporosis.
Solubilization of receptors in a functional state is a basic requirement for their purification. Attempts to solubilize the CT receptor using a variety of detergents including Lubrol-PX [5] , n-octyl /6-D-glucopyranoside and Triton X-100 (J. M. Moseley, unpublished work) have resulted in alteration of the binding characteristics so that little progress has been made with its purification. However, some success has been achieved with rat kidney membranes solubilized with Triton X-100 [6] .
Recently, we have identified high-affinity CT receptors in a human placental membrane fraction [7] . In this report, the solubilization of CT receptors from these membranes using the zwitterionic detergent, 3-[(3-cholamidopropyl)dimethylammonio]-1 -propanesulphonic acid (Chaps) [8] is described. The solubilized receptors retained all the characteristics of the membrane-bound receptor, including affinity, specificity and apparent Mr on SDS/polyacrylamide-gel electrophoresis (PAGE).
MATERIALS AND METHODS
Chemical and hormones Synthetic human CT (hCT) was provided by Dr. W. Rittel, Ciba-Geigy, Basle, Switzerland. Synthetic salmon CT (sCT), porcine CT (pCT), des-Leul6-sCT, des-Phe16-hCT and [Gly8]hCT were provided by Dr The membrane fraction was prepared from full-term human placentae as previously described [9] "5I-sCT binding to solubilized placental membranes '25I-Labelling of the peptides was carried out using low-concentration chloramine-T oxidation and QUSO G32 purification as previously described [12, 13] . Specific activities for all tracers were 150-200,Ci/,g. Several experiments were performed to determine the optimum conditions to separate receptor-bound 125I-sCT from free 125I-sCT. Precipitation of hormone-receptor complexes with polyethyleneglycol 6000 at a final concentration of 120 (w/v) and bovine y-globulin at a final concentration of 1 mg/ml produced satisfactory results. The routine binding assay was performed as follows: placental membrane extract was incubated overnight at 4 'C with 0.1 nM-1251-sCT alone or together with unlabelled peptides in 50 mM-Tris/HCl, 1 mM-EDTA, bovine serum albumin (0.2 mg/ml) and 4 mM-Chaps. Non-specific binding was assessed in the presence of excess unlabelled sCT (300 nM). Bound and free tracer were separated by the addition of bovine y-globulin and polyethyleneglycol 6000 in 100 mM-potassium phosphate buffer, pH 7. Photoaffinity labelling was carried out on both particulate placental membranes and on the extract of membranes solubilized in Chaps. All procedures, up to the irradiation step, were carried out under safe-light conditions. Placental membranes were incubated overnight at 4°C with 0.2 nM-1251-[Arg"' 18,4-azidobenzoylLys'4]sCT alone or together with unlabelled sCT in 100 mM-potassium phosphate buffer, 1 mM-EDTA and bovine serum albumin (1 mg/ml), pH 7.0. The membranes were centrifuged in a Beckman microfuge, washed and resuspended in the phosphate buffer, placed in a Petri dish on ice and irradiated for 15 min with a 100 W long-wave (peak emission of 366 nm) u.v. lamp at a distance of 10 cm. They were recentrifuged and the pellets solubilized in 50 mM-Tris/HCI, 1 % (w/v) SDS, 100% (v/v) glycerol, 5 00 (v/v) mercaptoethanol, pH6.8 (sample buffer). Extracts were heated at 95°C for 3 min, centrifuged at 105 000 g for 1 h and then analysed by SDS/PAGE by the method of Laemmli [14] .
Solubilized placental membrane extracts were treated in a similar way. After irradiation, 80 ,ul aliquots of the extract (containing -250 ,tg of protein) were added to 80 ,1 of double-strength sample buffer, boiled and subjected to SDS/PAGE. 
RESULTS

Detergent solubilization
The effect of increasing concentrations of Chaps on the solubilization of functional CT receptors from placental membranes is shown in Fig. 1 (Fig. 4) . Addition of excess unlabelled sCT at 1 h prevented further binding, but did not produce dissociation even after 18 h (Fig. 4) . Maximum binding was achieved more rapidly (by 90 min) at 22°C, but was only 7500 that achieved at 4°C (results not shown).
Saturation analysis
When solubilized extracts of placental membranes were incubated with increasing concentrations of 1251-sCT, the binding was saturable (Fig. 5a) 
Specificity
Competitive-binding studies (Fig. 6) showed that binding to the solubilized CT receptor retained the same high degree of specificity for CT as seen in the particulate membranes [7] . The relative potencies of species-specific CTs and analogues as observed in the hypocalcaemic bioassays [16] [17] [18] and binding assays [13, 19, 20] (Fig. 7a) . These bands were not seen in the absence of photolysis nor in the presence of excess (300 nM) unlabelled sCT and they were reduced in the presence of 0.1 or 0.3 nM-sCT. The results were essentially the same with solubilized extract (Fig. 7b) 
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(w/v) gels (Fig. 7) was not resolved using gradient gels of 7.5-15 o (w/v) acrylamide. Furthermore, bands of higher Mr were not seen when SDS/PAGE was performed under non-reducing conditions (results not shown). DISCUSSION The CT receptor has been difficult to obtain in significant amounts in solubilized form for several reasons. Although it is expressed in several cancer cell lines [12, 13, [19] [20] [21] several CT analogues to demonstrate preservation of the solubilized receptors' ability to recognize functional changes in CT structure. These problems have been overcome in the present work by using the zwitterionic detergent Chaps, which was specifically designed to combine the useful properties of the sulphobetaine-type and the bile salt anionic detergents [8] .
Solubilization of the placental CT receptor using 5 mM-Chaps resulted in complete preservation of receptor binding characteristics. The time course of binding was similar to that observed in particulate membranes [7] . Furthermore, as has been noted in various membrane preparations [21, 22] , rat osteoclasts [4] and human cancer cells [13, 19, 20] , as well as particulate placental membranes [7] , the binding was essentially irreversible. Accordingly, calculations of kinetic data using Scatchard A structural analogue of sCT, [Arg"1 18,Lys'4]sCT, which retains full biological activity after derivatization at the Lys"4 position, has been used to produce the photoactive, derivatized analogue [Arg"' 18,4-azidobenzoyl-Lys14]sCT. With this agent we have been able to photoaffinity label specific receptor components of Mr 88000 and -71000 in particulate placental membranes and in the solubilized extract. In the extract, each of these components consisted of duplex bands, either reflecting greater resolution or a detergent effect. Recently, we have used this sCT analogue derivatized with another photoactive cross-linking agent, 4-fluoro-3-nitrophenylazide, to demonstrate labelling of a single receptor component of Mr 85000 in placental membranes [7] . This was similar to our earlier results from chemical crossdIinking and photoaffinity-labelling experiments using 1251I-labelled native sCT, which identified single CT receptor components of Mr -80000-90000 on a human lung cancer cell line (BEN), human breast cancer cell lines (T47D and MCF 7) [23, 24] and rat osteoclasts [4] . Thus, the labelling of the Mr 71000 component is a new finding which could be a feature of the use of 1251-[Arg",1'8,4-azidobenzoyl-Lys'4]sCT as the photoaffinity agent in the placental CT receptor studies.
The results presented here show that Chaps can be used to solubilize CT receptors from placental membranes in a non-denatured form which retains all the binding characteristics of the membrane-bound receptor. This, together with identification of the abundant source of CT receptors in the placenta, provides new opportunities for purification of the CT receptor.
